Fulgent Genetics, Inc. (NASDAQ:FLGT) has scheduled a conference call for 4th August 2020 at 4:30 PM Eastern Time to announce its 2Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.fulgentgenetics.com
Earnings Expectation
Fulgent Genetics, Inc. is reporting second quarter financial results on Tuesday 4th August 2020, after market close.
According to analysts surveyed by Thomson Reuters, FLGT is expected to report 2Q20 loss of $ 0.02 per share from revenue of $ 10.02 million.
For the full year, analysts anticipate top line of $ 45.02 million, while looking forward to income of $ 0.12 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 40.00 million ~ $ 40.00 million
Click Here For More Historical Outlooks Of Fulgent Genetics, Inc.
Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions.
